Skandinaviska Enskilda Banken AB »

Halozyme Therapeutics shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 37k 73.34
2025-06-30 $2.7M 51k 52.00
2025-03-31 $4.3M 68k 63.78
2024-12-31 $1.5M 32k 48.00
2024-09-30 $2.7M 48k 57.21
2023-06-30 $400k 11k 36.08
2023-03-31 $614k 16k 38.17
2022-12-31 $659k 12k 56.90
2022-09-30 $1.2M 31k 39.55
2022-06-30 $2.3M 53k 44.01
2022-03-31 $2.1M 53k 39.89
2021-12-31 $13M 323k 40.32
2021-09-30 $14M 344k 40.68
2021-06-30 $8.9M 196k 45.41
2021-03-31 $8.2M 196k 41.69
2020-12-31 $2.6M 61k 42.72
2020-09-30 $2.1M 81k 26.28
2020-06-30 $866k 32k 26.81